Fore Capital »

Haemonetics shares owned by Fore Capital

Quarter-by-quarter ownership of Haemonetics shares owned by Fore Capital from 13F filings

Historical chart of Fore Capital investment in Haemonetics

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics held by Fore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics by Fore Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.6M 2.7M 0.95

More positions owned by Fore Capital

Ishares Silver Tr Ishares Call Option (SLV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Gold Tr Ishares New (IAU)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Vaneck Etf Trust Gold Miners Etf Put Option (GDX)
Etsy Note 0.250% 6/1 (Principal)
Centene Corporation (CNC)
Sprott Asset Management Physical Gold An (CEF)
NVIDIA Corporation Put Option (NVDA)
Novo-nordisk A S Adr (NVO)
Oil Sts Intl Note 4.750% 4/0 (Principal)

View all positions for Fore Capital

Top funds holding Haemonetics

Tenor Capital Management
Osterweis Capital Management
Franklin Resources
Readystate Asset Management
Millennium Management
Oaktree Capital Management
DeepCurrents Investment Group
MacKay Shields
State Street Corporation
Angelo, Gordon & Co
Aviva
Russell Investments
BlackRock
Bnp Paribas Investment Partners
Toronto-Dominion Bank

View all funds holding Haemonetics